Oxford BioDynamics (Oxford BioDynamics) FCF Margin % : -1,215.88% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Oxford BioDynamics's Free Cash Flow for the six months ended in Sep. 2023 was $-4.37 Mil. Oxford BioDynamics's Revenue for the six months ended in Sep. 2023 was $0.36 Mil. Therefore, Oxford BioDynamics's FCF Margin % for the quarter that ended in Sep. 2023 was -1,215.88%.

As of today, Oxford BioDynamics's current FCF Yield % is -36.12%.

The historical rank and industry rank for Oxford BioDynamics's FCF Margin % or its related term are showing as below:

OXBOF' s FCF Margin % Range Over the Past 10 Years
Min: -3946.75 Med: -284.82 Max: -70.11
Current: -1760.22

During the past 11 years, the highest FCF Margin % of Oxford BioDynamics was -70.11%. The lowest was -3946.75%. And the median was -284.82%.

OXBOF's FCF Margin % is ranked worse than
80.4% of 1041 companies
in the Biotechnology industry
Industry Median: -141.21 vs OXBOF: -1760.22

Oxford BioDynamics FCF Margin % Historical Data

The historical data trend for Oxford BioDynamics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics FCF Margin % Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Margin %

Get a 7-Day Free Trial

-319.95

-845.52

-2,643.59

-3,955.75

-1,767.19

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
FCF Margin %	Get a 7-Day Free Trial														-6,305.60	-3,416.07	-4,607.69	-2,492.13	-1,215.88

Competitive Comparison of Oxford BioDynamics's FCF Margin %

For the Biotechnology subindustry, Oxford BioDynamics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's FCF Margin % falls into.

Oxford BioDynamics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Oxford BioDynamics's FCF Margin for the fiscal year that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	-11.151	/	0.631
	=	-1,767.19 %

Oxford BioDynamics's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-4.365	/	0.359
	=	-1,215.88 %

Oxford BioDynamics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.